Enterprise Value
13.92M
Cash
44.94M
Avg Qtr Burn
-7.385M
Short % of Float
0.12%
Insider Ownership
4.42%
Institutional Own.
14.55%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CardiolRx™ Details COVID-19 | Phase 2/3 Update | |
CardiolRx™ Details Acute Myocarditis | Phase 2 Data readout | |
CardiolRx™ Details Recurrent pericarditis | Phase 2 Update |